October 13, 2023 - FDA Approves FUS for Liver Tumors and more news...

Published: October 13, 2023

October 13, 2023

US FDA Clears Focused Ultrasound to Noninvasively Treat Liver Tumors

The United States Food and Drug Administration (FDA) has cleared HistoSonics’ Edison histotripsy platform to treat liver tumors.
This is the ninth FDA-approved indication for focused ultrasound, and the first in the world approval for histotripsy.

Watch Now: Webinar on Sonodynamic Therapy for Brain Tumors

The Foundation and the National Brain Tumor Society hosted a webinar on sonodynamic therapy (SDT).
SDT uses focused ultrasound to activate agents that selectively accumulate in tumor cells to cause cell death.

Watch Now

Watch Now: Webinar on Focused Ultrasound and Breast Cancer

Webinar: Focused Ultrasound and Breast Cancer

The Foundation hosted a webinar on the use of focused ultrasound for treating breast cancer.
Researchers discussed using the technology to treat active disease and its potential applications during survivorship.

Watch Now

Clinical Trial Results: Noninvasive Brain Tumor Biopsy

Illustration of the neuronavigation-guided sonobiopsy setup.

Data from a first-in-human clinical trial using “sonobiopsy,” or focused ultrasound–enhanced liquid biopsy, were recently published.
The technique noninvasively enriched the blood circulating biomarkers that give physicians detailed information about the brain tumors.

Learn More

Focused Ultrasound Intellectual Property Update: Third Quarter 2023

The Foundation tracks patents issued by the US Patent Office related to the field.
Three new US patents for focused ultrasound have been issued since July 2023.

See the List

Forwarded this email by a friend? Sign up to receive these emails here.

And Don't Miss

Tune in Today at 1:00 pm Eastern | Profound Medical to Host Investor Day on October 13

Watch the Evolution of Histotripsy | Histotripsy: Ultrasound Cancer Treatment Approved by the FDA

See Recent News

Events

October 24-27, 2023 16th Clinical Trials on Alzheimer's Disease (CTAD) 2023, Boston, MA, USA

November 10-12, 2023 FOCAL2023: Frontiers in Oncologic Prostate Care and Ablative Local Therapy 2023, Chicago, IL, USA

November 11-15, 2023 Society for Neuroscience (SFN) Annual Meeting 2023, Washington, DC, USA

See All Upcoming Events

Do you have news for our newsletter? Tell us about it!

“We congratulate the HistoSonics team for their innovative work in this field, and we are encouraged that this first FDA clearance of a histotripsy application lays the groundwork for the technology to also treat benign and malignant tumors in other organs, such as the pancreas and kidneys.”

‒ Neal F. Kassell, MD

October 13, 2023 - FDA Approves FUS for Liver Tumors and more news...

Contact

Terms of Use